Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
14.2M
-
Shares change
-
+337K
-
Total reported value, excl. options
-
$263M
-
Value change
-
+$6.61M
-
Number of buys
-
21
-
Number of sells
-
-49
-
Price
-
$18.50
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q3 2020
89 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q3 2020.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.2M shares
of 100M outstanding shares and own 14.17% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (4.14M shares), Capital International Investors (1.34M shares), CAPITAL INTERNATIONAL INC (974K shares), FMR LLC (909K shares), Capital World Investors (875K shares), CREDIT SUISSE AG/ (700K shares), Nikko Asset Management Americas, Inc. (673K shares), Sumitomo Mitsui Trust Holdings, Inc. (660K shares), MORGAN STANLEY (522K shares), and Bpifrance SA (426K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.